|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van der Stok EP, Spaander MCW, Grunhagen
DJ, Verhoef C and Kuipers EJ: Surveillance after curative treatment
for colorectal cancer. Nat Rev Clin Oncol. 14:297–315. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tokunaga R, Imamura Y, Nakamura K,
Uchihara T, Ishimoto T, Nakagawa S, Iwatsuki M, Baba Y, Sakamoto Y,
Miyamoto Y, et al: Carbohydrate antigen 19-9 is a useful prognostic
marker in esophagogastric junction adenocarcinoma. Cancer Med.
4:1659–1666. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Daitoku N, Miyamoto Y, Tokunaga R,
Sakamoto Y, Hiyoshi Y, Iwatsuki M, Baba Y, Iwagami S, Yoshida N and
Baba H: Controlling nutritional status (CONUT) score is a
prognostic marker in metastatic colorectal cancer patients
receiving first-line chemotherapy. Anticancer Res. 38:4883–4888.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Daitoku N, Miyamoto Y, Sakamoto Y,
Tokunaga R, Hiyoshi Y, Nagai Y, Iwatsuki M, Iwagami S, Yoshida N
and Baba H: Prognostic significance of serum p53 antibody according
to KRAS status in metastatic colorectal cancer patients. Int J Clin
Oncol. 25:651–659. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taniguchi H, Yamazaki K, Yoshino T, Muro
K, Yatabe Y, Watanabe T, Ebi H, Ochiai A, Baba E and Tsuchihara K;
Japanese Society of Medical Oncology, : Japanese society of medical
oncology clinical guidelines: RAS (KRAS/NRAS) mutation testing in
colorectal cancer patients. Cancer Sci. 106:324–327. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoshino T, Arnold D, Taniguchi H,
Pentheroudakis G, Yamazaki K, Xu RH, Kim TW, Ismail F, Tan IB, Yeh
KH, et al: Pan-Asian adapted ESMO consensus guidelines for the
management of patients with metastatic colorectal cancer: A
JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann
Oncol. 29:44–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Forones NM and Tanaka M: CEA and CA 19-9
as prognostic indexes in colorectal cancer. Hepatogastroenterology.
46:905–908. 1999.PubMed/NCBI
|
|
9
|
Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M,
Tokunaga R, Kurashige J, Hiyoshi Y, Iwagami S, Yoshida N, Yoshida
M, et al: Sarcopenia is a negative prognostic factor after curative
resection of colorectal cancer. Ann Surg Oncol. 22:2663–2668. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M,
Tokunaga R, Kurashige J, Hiyoshi Y, Iwagami S, Yoshida N, Watanabe
M and Baba H: Negative impact of skeletal muscle loss after
systemic chemotherapy in patients with unresectable colorectal
cancer. PLoS One. 10:e01297422015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Evans WJ: Skeletal muscle loss: Cachexia,
sarcopenia, and inactivity. Am J Clin Nutr. 91:1123S–1127S. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kitano Y, Yamashita YI, Saito Y, Nakagawa
S, Okabe H, Imai K, Komohara Y, Miyamoto Y, Chikamoto A, Ishiko T
and Baba H: Sarcopenia affects systemic and local immune system and
impacts postoperative outcome in patients with extrahepatic
cholangiocarcinoma. World J Surg. 43:2271–2280. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Harada K, Ida S, Baba Y, Ishimoto T,
Kosumi K, Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y, et
al: Prognostic and clinical impact of sarcopenia in esophageal
squamous cell carcinoma. Dis Esophagus. 29:627–633. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Levolger S, van Vugt JL, de Bruin RW and
JN IJ: Systematic review of sarcopenia in patients operated on for
gastrointestinal and hepatopancreatobiliary malignancies. Br J
Surg. 102:1448–1458. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gaddykurten D, Tsuchida K and Vale W:
Activins and the receptor serine kinase superfamily. Recent Prog
Horm Res. 50:109–129. 1995.PubMed/NCBI
|
|
16
|
Miyamoto Y, Hanna DL, Zhang W, Baba H and
Lenz HJ: Molecular pathways: Cachexia signaling-a targeted approach
to cancer treatment. Clin Cancer Res. 22:3999–4004. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lokireddy S, Wijesoma IW, Bonala S, Wei M,
Sze SK, McFarlane C, Kambadur R and Sharma M: Myostatin is a novel
tumoral factor that induces cancer cachexia. Biochem J. 446:23–36.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lyu S, Jiang C, Xu R, Huang Y and Yan S:
INHBA upregulation correlates with poorer prognosis in patients
with esophageal squamous cell carcinoma. Cancer Manag Res.
10:1585–1596. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oshima T, Yoshihara K, Aoyama T, Hasegawa
S, Sato T, Yamamoto N, Akito N, Shiozawa M, Yoshikawa T, Numata K,
et al: Relation of INHBA gene expression to outcomes in gastric
cancer after curative surgery. Anticancer Res. 34:2303–2309.
2014.PubMed/NCBI
|
|
20
|
Katayama Y, Oshima T, Sakamaki K, Aoyama
T, Sato T, Masudo K, Shiozawa M, Yoshikawa T, Rino Y, Imada T and
Masuda M: Clinical significance of INHBA gene expression in
patients with gastric cancer who receive curative resection
followed by adjuvant S-1 chemotherapy. In Vivo. 31:565–571. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okano M, Yamamoto H, Ohkuma H, Kano Y, Kim
H, Nishikawa S, Konno M, Kawamoto K, Haraguchi N, Takemasa I, et
al: Significance of INHBA expression in human colorectal cancer.
Oncol Rep. 30:2903–2908. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hoda MA, Rozsas A, Lang E, Klikovits T,
Lohinai Z, Torok S, Berta J, Bendek M, Berger W, Hegedus B, et al:
High circulating activin a level is associated with tumor
progression and predicts poor prognosis in lung adenocarcinoma.
Oncotarget. 7:13388–13399. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sauerbrei W, Taube SE, McShane LM,
Cavenagh MM and Altman DG: Reporting recommendations for tumor
marker prognostic studies (REMARK): An abridged explanation and
elaboration. J Natl Cancer Inst. 110:803–811. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hoda MA, Munzker J, Ghanim B, Schelch K,
Klikovits T, Laszlo V, Sahin E, Bedeir A, Lackner A, Dome B, et al:
Suppression of activin a signals inhibits growth of malignant
pleural mesothelioma cells. Br J Cancer. 107:1978–1986. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou X, Wang JL, Lu J, Song Y, Kwak KS,
Jiao Q, Rosenfeld R, Chen Q, Boone T, Simonet WS, et al: Reversal
of cancer cachexia and muscle wasting by ActRIIB antagonism leads
to prolonged survival. Cell. 142:531–543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Janssen I, Heymsfield SB and Ross R: Low
relative skeletal muscle mass (sarcopenia) in older persons is
associated with functional impairment and physical disability. J Am
Geriatr Soc. 50:889–896. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Loumaye A, de Barsy M, Nachit M, Lause P,
van Maanen A, Trefois P, Gruson D and Thissen JP: Circulating
activin A predicts survival in cancer patients. J Cachexia
Sarcopenia Muscle. 8:768–777. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhong XL, Pons M, Poirier C, Jiang Y, Liu
J, Sandusky GE, Shahda S, Nakeeb A, Schmidt CM, House MG, et al:
The systemic activin response to pancreatic cancer: Implications
for effective cancer cachexia therapy. J Cachexia Sarcopenia
Muscle. 10:1083–1101. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsuzaki K: Smad phosphoisoform signaling
specificity: The right place at the right time. Carcinogenesis.
32:1578–1588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Albano D, Messina C, Vitale J and
Sconfienza LM: Imaging of sarcopenia: Old evidence and new
insights. Eur Radiol. 30:2199–2208. 2020. View Article : Google Scholar : PubMed/NCBI
|
